Table 14.
Survival rate (months) | P-value | |||
---|---|---|---|---|
<12 N=93 |
12–24 N=46 |
>24 N=82 |
||
Surgery only (n=18) | 9 (50.0%) | 4 (22.2%) | 5 (27.8%) | 0.680 |
Radiotherapy only (n=30) | 8 (26.7%) | 6 (20.0%) | 16 (53.3%) | 0.109 |
Chemotherapy only (n=22) | 20 (91.0%) | 1 (4.5%) | 1 (4.5%) | <0.001 |
Surg. & Rad. (n=30) | 8 (26.7%) | 6 (20.0%) | 16 (53.3%) | 0.063 |
Surg. & Chem. (n=16) | 12 (75.0%) | 1 (6.2%) | 3 (18.8%) | 0.039 |
Rad. & Chem. (n=52) | 13 (25.0%) | 15 (28.8%) | 24 (46.2%) | 0.005 |
Surg. & Rad. & Chem. (n=44) | 4 (9.1%) | 13 (29.6%) | 27 (61.4%) | <0.001 |
Note: Bold value represents statistically significant.